Review article Alessandro Mantovani 1,2 , Riccardo Morandin 1,2 , Nicoletta Rolli 1,2 , Elisa Molinaroli 1,2 , Giovanni Targher 1 [*] ,2 1 Department of Medicine, University of Verona, Verona, Italy 2 Metabolic Diseases Research Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy EXCLI J 2026;25:Doc803 Abstract Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (T2DM) are two common, interconnected conditions that pose a major global health challenge
When you have an injury, your body needs cells (like fibroblasts) to migrate from healthy areas to the damaged site
The Importance of a Holistic Approach In spite of their effectiveness, GLP-1 medications are not standalone solutions
Can I combine peptide therapy with other treatments
Dial in your calorie burn for over 100 activities
This is where PT-141 differs from drugs used for erectile dysfunction